Pivotal trial of Rett gene therapy TSHA-102 now underway, and recruiting

Rett Syndrome News·Jan 7

This story is reported by Rett Syndrome News. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Embolden gene therapy trial finishes dosing ahead of schedule

Rett Syndrome News·Jun 17

2

Pivotal trial tests new gene therapy approach for Rett syndrome

Rett Syndrome News·Jan 14

3

Gene therapy NGN-401 leads to functional gains in Rett syndrome

Rett Syndrome News·Dec 3

4

All Rett patients in trial achieve motor milestones with gene therapy

Rett Syndrome News·Jun 24

5

Taysha regains full rights to TSHA-102 gene therapy for Rett

Rett Syndrome News·Oct 22

6

Taysha, FDA agree on next steps of REVEAL trial for Rett gene therapy

Rett Syndrome News·May 21

7

RSRT launches program to advance genetic therapies for Rett

Rett Syndrome News·Jun 12

8

Phase 2 extension trial shows sustained benefits of Anavex 2-73 –...

Rett Syndrome News·Jul 5